CVS Health
CVS
1,916 hedge funds and large institutions have $60.6B invested in CVS Health in 2024 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 575 increasing their positions, 1,043 reducing their positions, and 369 closing their positions.
29% more call options, than puts
Call options by funds: $1.63B | Put options by funds: $1.26B
17% more capital inflows, than outflows
Capital inflows: $8.57B | Capital outflows: $7.31B
1.73% more ownership
Funds ownership: 79.97% → 81.7% (+1.7%)
12% less funds holding
Funds holding: 2,184 → 1,916 (-268)
34% less funds holding in top 10
Funds holding in top 10: 41 → 27 (-14)
45% less repeat investments, than reductions
Existing positions increased: 575 | Existing positions reduced: 1,043
64% less first-time investments, than exits
New positions opened: 131 | Existing positions closed: 369
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$1.4B |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$1.29B |
| 3 |
BlackRock
New York
|
+$816M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$766M |
| 5 |
Glenview Capital Management
New York
|
+$467M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$1.07B |
| 2 |
Morgan Stanley
New York
|
-$387M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$344M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$316M |
| 5 |
Lazard Asset Management
New York
|
-$186M |
CVS Hedge Fund Activity: Q2 2024 in Review
1,916 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2024, worth a combined $60.6B — down 24% from $80.1B a quarter earlier.
Sellers outnumbered buyers: 369 funds closed out of CVS and 131 opened new positions — a net loss of 238 holders — while 1,043 trimmed existing stakes and 575 added.
The largest buyer was Capital Research Global Investors, adding an estimated $1.4B. The largest seller was Capital International Investors, cutting an estimated $1.07B.
- 1,916 institutional investors held CVS Health (CVS) as of Q2 2024, down from 2,184 in Q1 2024.
- Funds reported $60.6B of CVS Health stock for Q2 2024, down 24% quarter-over-quarter.
- 131 funds opened new CVS Health positions in Q2 2024 and 369 closed out, a net change of -238 holders.
- The largest CVS Health buyer in Q2 2024 was Capital Research Global Investors, an estimated $1.4B added.
- The largest CVS Health seller in Q2 2024 was Capital International Investors, an estimated $1.07B sold.
Based on aggregated 13F filings for Q2 2024.